Status:
COMPLETED
Impact of Obsidian ® ASG on Anastomotic Healing
Lead Sponsor:
Kepler University Hospital
Conditions:
Anastomotic Leak Rectum
Eligibility:
All Genders
18+ years
Brief Summary
The use of regenerative medicine in colorectal surgery constitutes an entirely new therapeutic principle. The aim of this new therapeutic approach is to reduce the anastomotic leak rate and minimise m...
Detailed Description
Introduction: The use of regenerative medicine in colorectal surgery constitutes an entirely new therapeutic principle. The aim of this new therapeutic approach is to reduce the anastomotic leak rate...
Eligibility Criteria
Inclusion
- elective laparoscopic colorectal surgery with a primary anastomosis treatment
Exclusion
- pregnancy
- Breastfeeding period
- concomitant disease with the potential for a relevant impairment of the anastomosis durability (leukemia, cirrhosis of the liver, Child Pugh A-C)
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT04386148
Start Date
June 1 2018
End Date
December 31 2021
Last Update
October 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic for General and Visceral Surgery, Kepler University Clinic Linz
Linz, Upper Austria, Austria, 4020